Rockley Photonics Holdings Ltd

OXFORD, England & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax agency of the UK government. The Company filed its fiscal 2021 R&D tax credit application and expects to file its fiscal 2022 R&D tax credit application in 2023.

Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application

OXFORD, England, & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received a notice from the New York Stock Exchange (“NYSE”) on December 9, 2022, indicating that the Company is not in compliance with NYSE's continued listing standards, which require an average market capitalization of not less than $50 million over a 30 trading-day period and stockholders' equity of not less than $50 million. The notice has no immediate impact on the listing of Rockley's common stock on the NYSE, subject to the Company's compliance with the NYSE's other continued listing requirements, except that its ticker symbol will continue to have an added designation of “.BC” to indicate the status of its ordinary shares as below compliance with the NYSE continued listing standards. The “.BC” indicator will be removed when it regains compliance.

Rockley Photonics Announces Receipt of Notice from NYSE of Non-Compliance with Continued Listing Standards

OXFORD, England & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced changes to its senior management team. These changes are intended to position the Company for its next phase of growth.

Rockley Photonics Announces Promotion of Richard A. (Randy) Meier to Chief Executive Officer

OXFORD, England & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that Dr. Andrew Rickman, OBE, will join heads of government, senior ministers, and business leaders from across the Commonwealth to participate in the Commonwealth Trade and Investment Summit 2022.

Rockley Photonics' CEO Andrew Rickman to Speak at the Commonwealth Trade and Investment Summit 2022

OXFORD, England & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced a groundbreaking 4-Kelvin performance demonstration with its monolithic silicon photonics electro-absorption modulator technology that is key to the development of next-generation cryogenic interconnect technology. This advancement is intended to enable ultra-sensitive image detection and sensing devices to view and capture images more clearly and at longer distances, as well as in low-light situations and enables these devices to have a significantly reduced size and weight.

Rockley Photonics Demonstrates Compact 4-Kelvin Silicon Photonics Modulator Enabling Interconnect Technologies for Ultra-sensitive Image Detection and Sensing Devices

OXFORD, England & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it will participate in the following investor conferences.

Rockley Photonics to Present at Upcoming Conferences

Rockley Photonics Holdings Limited (NYSE:RKLY ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Company Participants Gwyn Lauber - VP, IR Andrew Rickman - Founder, Chairman, President & CEO Richard Meier - President and CFO Conference Call Participants Quinn Bolton - Needham & Company Paul Silverstein - Cowen and Company Tim Savageaux - Northland Capital Markets Operator Greetings, and welcome to the Rockley Photonics Third Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode.

Rockley Photonics Holdings Limited (RKLY) Q3 2022 Earnings Call Transcript

Rockley Photonics Holdings Limited (RKLY) delivered earnings and revenue surprises of 80.77% and 72.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Rockley Photonics Holdings Limited (RKLY) Reports Q3 Loss, Lags Revenue Estimates

Rockley Photonics Reports Third Quarter of Fiscal 2022 Financial Results

Rockley Photonics Announces Date of Third Quarter 2022 Financial Results Release

Rockley Photonics Announces $90.6 Million Private Placement of New Convertible Notes and Warrants and Repurchase of $63.9 Million of Bridge Notes and Existing Convertible Notes

Rockley Photonics Appoints Healthcare Industry Veteran Richard A. “Randy” Meier President and Chief Financial Officer

Rockley Photonics Completes Human Study Demonstrating Promising Intra-Subject Tracking Against Standard Blood Pressure Cuff, Utilizing Its Non-Invasive, Cuffless, and Laser-Based Device

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)---- $RKLY #freelivingstudy--Rockley Photonics Expands Free-Living Human Study of Its Bioptx Biosensing Band Across Broader Group of Participants

Rockley Photonics to Expand Free-Living Human Study of Its Bioptx Biosensing Band Across Broader Group of Participants

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)---- $RKLY #earnings--Rockley Photonics Raises Additional Financing

Rockley Photonics Raises Additional Financing

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced that it has developed what it believes to be the world's first micro-transfer-printed (mTP) silicon-photonics-based laser for commercial applications. This groundbreaking achievement is expected to allow Rockley to further increase the density and reduce the size of its high-density sp

Rockley Photonics Unveils Next-Generation, Higher-Density Laser Spectrophotometer Chip for Wearable Health Monitoring

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)---- $RKLY #earnings--Rockley Photonics to Present at Upcoming Conference

Rockley Photonics to Present at Upcoming Conference

Rockley Photonics Holdings Ltd (NYSE:RKLY ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Gwyn Lauber - VP, IR Andrew Rickman - Founder, Chairman, President & CEO Chad Becker - Interim CFO Conference Call Participants Nathaniel Bolton - Needham & Company Paul Silverstein - Cowen and Company Timothy Savageaux - Northland Capital Markets Operator Welcome, and thank you for joining us today for this Rockley Photonics Second Quarter 2022 Conference Call. As a reminder, all phone participants are in a listen-only mode and later you will have the opportunity to ask questions.

Rockley Photonics Holdings Ltd (RKLY) CEO Andrew Rickman on Q2 2022 Results - Earnings Call Transcript

Rockley Photonics Holdings Limited (RKLY) delivered earnings and revenue surprises of -241.67% and 49.83%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Rockley Photonics Holdings Limited (RKLY) Reports Q2 Loss, Misses Revenue Estimates

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)---- $RKLY #earnings--Rockley Photonics Holdings Limited (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced its financial results for the second quarter ended June 30, 2022. “I am proud of the progress we made in the second quarter. As we ramp towards commercial production, we have reached many of the milestones that we've been working towards and expect to reach many more in the coming months,” said Dr

Rockley Photonics Reports Second Quarter of Fiscal 2022 Financial Results

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced the formation of a scientific advisory board (SAB) gathering world-renowned experts across several key disciplines in biomedical science and technology, including spectroscopy, diabetes technology, hydration science, and cardiology. The newly formed SAB will support Rockley's mission o

Rockley Establishes Scientific Advisory Board of Prominent Scientists and Medical Experts

OXFORD, England, and PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced that it has signed a supply agreement outlining the customer's initial purchase commitment for 2023 and received the first commercial purchase order for its non-invasive biomarker sensing wristbands from a global healthcare technology provider. The Bioptx™ Baseline devices included

Rockley Photonics Signs Supply Agreement and Receives First Commercial Purchase Order for Its Non-Invasive Biosensing Wristband

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)---- $RKLY #boardofdirectors--Rockley Photonics Names Richard Kuntz, M.D., to Board of Directors

Rockley Photonics Names Richard Kuntz, M.D., to Board of Directors

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced a new partnership with a top ten, global contract research organization (CRO) that provides full-service clinical development services to biopharmaceutical customers. Under the agreement, the CRO and Rockley will collaborate on strategic programs to integrate Rockley's health monitorin

Rockley Photonics Announces Strategic Partnership with Leading Contract Research Organization

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)---- $RKLY #earnings--Rockley Photonics (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it plans to report its second quarter 2022 financial results after the market closes on Thursday, August 11, 2022. The company also plans to host a conference call that day at 5:00 p.m. Eastern Time to review its financial results and business outlook. The conference call can be accessed by dialing 866-682-61

News for Rockley Photonics Holdings Ltd Stock (RKLY)